389 Chronic Diarrhea in Subset of Patients With IBD and IBS is Associated With Altered Microbiota
Vayu Maini Rekdal(Harvard University), Purna Kashyap(Mayo Clinic), Madhusudan Grover(Mayo Clinic), Nicholas Chia(Mayo Clinic), John F. Rainey(Mayo Clinic), Edward V. Loftus(Mayo Clinic), Mhd Firas Alnahhas, Sahil Khanna(Mayo Clinic), M Donna Felmlee Devine, David A. Ahlquist(Mayo Clinic), Christopher S. Reigstad(Mayo Clinic), Gianrico Farrugia(Mayo Clinic), Darrell S. Pardi(Mayo Clinic)
Cited by 0
Related Papers
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target
|The American Journal of Gastroenterology|2015|1.8k
Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease
|New England Journal of Medicine|2016|1.8k
Gut microbes promote colonic serotonin production through an effect of short‐chain fatty acids on enterochromaffin cells
|The FASEB Journal|2014|1.3k
Microbiota-liberated host sugars facilitate post-antibiotic expansion of enteric pathogens
|Nature|2013|1.1k
Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls
|Scientific Reports|2016|973